CYCLOPHOSPHAMIDE
Phase 3 small_molecule active
Quick answer
CYCLOPHOSPHAMIDE for The study will involve adult women and men from 16 French centers who have hematological malignancies and are candidates for haploidentical HSCT is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- The study will involve adult women and men from 16 French centers who have hematological malignancies and are candidates for haploidentical HSCT
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active